Enzon Pharmaceuticals, Inc.

Japan has set reimbursement prices for six new drugs under its national health insurance (NHI) scheme - including a gene therapy with the second-highest unit price ever for a therapeutic product in th

The upcoming advisory committee reviews of the first coronavirus vaccine(s) and Biogen, Inc. ’s aducanumab for Alzheimer’s should be two historic panel meetings, prompting a look back at

FDA staff must have entered the long US Columbus Day weekend with clean desks thanks to a flurry of late Friday actions on Oct. 5. The approval of novel agents from Ionis (the antisense agent Tegsedi

Charles Hugh-Jones has left his position as chief medical officer at Pfizer Oncology to join Allergan PLC in the same position, reporting into chief R&D officer David Nicholson. Hugh-Jones has 25